Cabaletta Bio Statistics

Total Valuation

Cabaletta Bio has a market cap or net worth of $64.44 million. The enterprise value is -$83.92 million.

Market Cap	64.44M
Enterprise Value	-83.92M

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025, before market open.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Cabaletta Bio has 50.74 million shares outstanding. The number of shares has increased by 19.77% in one year.

Current Share Class	50.74M
Shares Outstanding	50.74M
Shares Change (YoY)	+19.77%
Shares Change (QoQ)	+1.34%
Owned by Insiders (%)	4.17%
Owned by Institutions (%)	65.01%
Float	42.83M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.42
P/TBV Ratio	0.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.15, with a Debt / Equity ratio of 0.10.

Current Ratio	6.15
Quick Ratio	6.05
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-167.30

Financial Efficiency

Return on equity (ROE) is -59.64% and return on invested capital (ROIC) is -38.23%.

Return on Equity (ROE)	-59.64%
Return on Assets (ROA)	-35.66%
Return on Invested Capital (ROIC)	-38.23%
Return on Capital Employed (ROCE)	-79.22%
Revenue Per Employee	n/a
Profits Per Employee	-$706,488
Employee Count	164
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -90.12% in the last 52 weeks. The beta is 2.44, so Cabaletta Bio's price volatility has been higher than the market average.

Beta (5Y)	2.44
52-Week Price Change	-90.12%
50-Day Moving Average	1.62
200-Day Moving Average	3.49
Relative Strength Index (RSI)	45.38
Average Volume (20 Days)	949,467

Short Selling Information

The latest short interest is 5.80 million, so 11.43% of the outstanding shares have been sold short.

Short Interest	5.80M
Short Previous Month	6.13M
Short % of Shares Out	11.43%
Short % of Float	13.54%
Short Ratio (days to cover)	7.11

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-125.14M
Pretax Income	-89.98M
Net Income	-115.86M
EBITDA	-123.43M
EBIT	-125.14M
Earnings Per Share (EPS)	-$2.36

Full Income Statement

Balance Sheet

The company has $163.96 million in cash and $15.60 million in debt, giving a net cash position of $148.36 million or $2.92 per share.

Cash & Cash Equivalents	163.96M
Total Debt	15.60M
Net Cash	148.36M
Net Cash Per Share	$2.92
Equity (Book Value)	152.34M
Book Value Per Share	3.00
Working Capital	139.59M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$88.22 million and capital expenditures -$2.21 million, giving a free cash flow of -$90.43 million.

Operating Cash Flow	-88.22M
Capital Expenditures	-2.21M
Free Cash Flow	-90.43M
FCF Per Share	-$1.78

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Cabaletta Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.77%
Shareholder Yield	n/a
Earnings Yield	-179.79%
FCF Yield	-140.33%

Analyst Forecast

The average price target for Cabaletta Bio is $21.00, which is 1,540.63% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.00
Price Target Difference	1,540.63%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-8.98%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1